Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Body Checking Injuries in National Collegiate Athletic Association Men's Ice Hockey: Findings From the NCAA Injury Surveillance Program 2009/10 to 2019/20
Boltz, Adrian J. , Garcia, Reagan E., Collins, Christy L. , Alexander, Andrew , Alexander, Andrew S , Alexander, Andrew S., Mihalik, Jason P. , Chandran, Avinash S.

Clinical Journal of Sport Medicine | July 9, 2024 | Volume: 34 | Issue: 6 | Pages: 583-590

10.1097/jsm.0000000000001255 | PMID 38980686 Get It

Objective: To describe the epidemiology of body checking injuries in the National Collegiate Athletic Association (NCAA) Men's Ice Hockey. Design: Secondary data analysis of historical cohort data. Setting: A convenience sample of injuries in NCAA Men's Ice Hockey during the 2009/10 to 2019/20 academic years. Patients (or Participants) NCAA student-athletes. Independent Variables: Event type, season, time loss, body part, diagnosis, player position, and mechanism. Main Outcome Measures: This study examined injuries that occurred during practice or competition, regardless of time loss, reported to the NCAA Injury Surveillance Program. Injury counts, rates, and proportions were used. The injury rate and proportion ratios with 95% confidence intervals were also constructed. Three independent logistic regression models were constructed to examine differential odds of time loss (≥1 day; TL) injury and the 2 most common injuries, between body checking injuries and all other injuries. Results: Overall, 1290 body checking injuries (rate = 1.59/1000 athlete-exposures) were reported during the study period. Most were attributed to the upper extremity (42%) or head/neck (27%). The competition injury rate generally decreased after 2012/13. After adjusting for covariates, odds of (1) a TL injury was lower and (2) an acromioclavicular sprain was higher among body checking injuries as compared with injuries attributed to all other activities. Odds of concussion was not associated with body checking injuries. Conclusions: Body checking injuries were frequently attributed to the head/neck and upper extremities, and the rate of these injuries during competition appeared to be decreasing. Still, improvements in helmet and shoulder pad technology may further improve health and safety.
Tranexamic Acid Administered at Time of Hospital Admission Does Not Decrease Transfusion Rates or Blood Loss for Extracapsular Hip Fractures: A Double-Blinded Randomized Clinical Trial
Owen, Aaron R. , Boe, Chelsea C., Kuttner, Nicolas P. , Cancio-Bello, Alexandra , Colbenson, Kristina M., Cross, William W., Sems, S.A. , Yuan, Brandon J. , Cancio-Bello, Alexandra M, Yuan, Brandon , Hidden, Krystin A. , Barlow, Jonathan D.

Journal of Orthopaedic Trauma | July 9, 2024 | Volume: 38 | Issue: 10 | Pages: 515-520

10.1097/bot.0000000000002870 | PMID 39325048 Get It

OBJECTIVES: To evaluate tranexamic acid (TXA) when administered immediately on hospital presentation in patients with extracapsular peritrochanteric hip fractures to determine its effect on (1) transfusion rates, (2) estimated blood loss, and (3) complications. METHODS: Design: Prospective, double-blinded, randomized clinical trial. Setting: Single-center, Level 1 trauma center. Patient Selection Criteria: All patients with isolated OTA/AO 31-A fracture patterns from 2018 to 2022 were eligible for inclusion. Study drug was administered in the emergency department at the time of presentation—1-g bolus over 10 minutes followed by a 1-g infusion over 8 hours. Outcome Measures and Comparisons: The primary outcome was the rate of red blood cell transfusion hospital days 1–4. Secondary outcomes included estimated blood loss and complications including venous thromboembolic events, stroke, myocardial infarction, all-cause 90-day readmissions, and all-cause mortality. RESULTS: One hundred twenty-eight patients were included—64 patients were randomized to intravenous TXA and 64 patients to intravenous normal saline (ie, placebo). There was no difference in the rate of red blood cell transfusion between treatment arms between hospital days 1–4 (27% in the TXA arm vs. 31% in the placebo arm, P = 0.65). Patients randomized to placebo who required transfusion received a mean of 2.30 units compared with 1.94 units in the TXA cohort (P = 0.55). There was no difference in the estimated blood loss between hospital days 1–4. There was no difference in the incidence of postoperative complications including venous thromboembolic events, stroke, myocardial infarction, 90-day readmission, or death. CONCLUSIONS: The results of this study do not support the use of preoperative TXA for reducing blood loss for geriatric patients with extracapsular hip fractures. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course
Zar, Heather J. , Siroux, Valérie , Saglani, Sejal , Koppelman, Gerard H. , Gern, James E. , Gaston, Benjamin , Zein, Joe , Gern, James E , Melén, Erik , Shaw, Dominick E. , Hartert, Tina V. , Bush, Andrew

American Journal of Respiratory and Critical Care Medicine | July 9, 2024 | Volume: 210 | Issue: 6 | Pages: 737-754

10.1164/rccm.202312-2249so | PMID 38981012 Get It

Abstract Asthma is a descriptive label for an obstructive inflammatory disease in the lower airways manifesting with symptoms including breathlessness, cough, difficulty in breathing, and wheezing. From a clinician’s point of view, asthma symptoms can commence at any age, although most patients with asthma—regardless of their age of onset—seem to have had some form of airway problems during childhood. Asthma inception and related pathophysiologic processes are therefore very likely to occur early in life, further evidenced by recent lung physiologic and mechanistic research. Herein, we present state-of-the-art updates on the role of genetics and epigenetics, early viral and bacterial infections, immune response, and pathophysiology, as well as lifestyle and environmental exposures, in asthma across the life course. We conclude that early environmental insults in genetically vulnerable individuals inducing abnormal, pre-asthmatic airway responses are key events in asthma inception, and we highlight disease heterogeneity across ages and the potential shortsightedness of treating all patients with asthma using the same treatments. Although there are no interventions that, at present, can modify long-term outcomes, a precision-medicine approach should be implemented to optimize treatment and tailor follow-up for all patients with asthma.
Mentored Practice in AOTA Fellowship Programs: An Exploratory Phenomenological Study
Bergstrom, Jennifer

Journal of Occupational Therapy Education | July 9, 2024 | Volume: 8 | Issue: 1 | Pages: No page available

10.26681/jote.2024.080112 Get It

Adding Dexmedetomidne to Intra‐articular Local Anesthetics Results in Prolonged Analgesia After Knee Arthroscopy: A Systematic Review and Meta‐analysis
Terres, Marcela Tatsch , Assis, Maria Luisa Machado, Lombardi, Rafael , Silveira, Carlos Balthazar da, Amaral, Sara , Machado Assis, Maria Luisa, Silveira, Carlos André Balthazar da

Arthroscopy | July 9, 2024 | Volume: 41 | Issue: 4 | Pages: 1061

10.1016/j.arthro.2024.06.043 | PMID 38992512 Get It

Purpose To assess the efficacy and safety of dexmedetomidine as an adjuvant to intra‐articular (IA) injections of local anesthetics (LA) in adult patients undergoing knee arthroscopy. Methods We searched MEDLINE, Embase, and Cochrane Library for randomized controlled trials (RCTs) comparing IA dexmedetomidine plus LA versus LA alone for knee arthroscopy in adults. We used the DerSimonian and Laird random‐effects model for all outcomes and conducted a sensitivity analysis with the leave‐one‐out method, as well as a subgroup analysis for the type of LA. We used R version 4.1.2 for all statistical analyses. Results We included 16 RCTs encompassing 799 patients, of whom 49.8% received IA dexmedetomidine. In the pooled analysis, time to first analgesia rescue was prolonged in almost 4 hours with the use of dexmedetomidine (mean difference [MD] 229 minutes; P < .001). We found statistically significant differences favoring dexmedetomidine in pain scores at rest and movement throughout the first 2, 6, 12, and 24 hours postoperatively ( P < .001). Although the MD ranged from –0.3 to –0.9 cm, corresponding to a 3% to 9% reduction in pain scores, this change is not clinically significant compared with the minimal clinically important difference (MCID). Additionally, the intervention group showed a statistically significant reduction in cumulative opioid consumption over 24 hours (MD –4.5 mg; P < .001). However, this reduction did not meet the threshold for the MCID. There was no difference between groups on the incidence of hypotension ( P = .190), bradycardia ( P = .430), and postoperative nausea and vomiting ( P = .550). Conclusions Adding dexmedetomidine to LA in IA injections for knee arthroscopy significantly extended analgesia duration. Additionally, it lowered pain scores and opioid use, although these effects did not reach the MCID. Furthermore, this addition did not increase the risk of adverse events. Level of Evidence Level II, meta‐analysis of Level I and II studies.
Identification of ChatGPT‐Generated Abstracts Within Shoulder and Elbow Surgery Poses a Challenge for Reviewers
Stadler, Ryan D. , Sudah, Suleiman Y. , Denard, Patrick J. , Duralde, Xavier A. , Garrigues, Grant E. , Klifto, Christopher S. , Namdari, Surena , Sánchez‐Sotelo, Joaquín , Menendez, Mariano E. , Sanchez-Sotelo, Joaquin, Sanchez-Sotelo, J. , Denard, Patrick J , Moverman, Michael A. , Levy, Jonathan C., Menendez, Mariano E.

Arthroscopy | July 9, 2024 | Volume: 41 | Issue: 4 | Pages: 916

10.1016/j.arthro.2024.06.045 | PMID 38992513 Get It

Purpose To evaluate the extent to which experienced reviewers can accurately discern between artificial intelligence (AI)–generated and original research abstracts published in the field of shoulder and elbow surgery and compare this with the performance of an AI detection tool. Methods Twenty‐five shoulder‐ and elbow‐related articles published in high‐impact journals in 2023 were randomly selected. ChatGPT was prompted with only the abstract title to create an AI‐generated version of each abstract. The resulting 50 abstracts were randomly distributed to and evaluated by 8 blinded peer reviewers with at least 5 years of experience. Reviewers were tasked with distinguishing between original and AI‐generated text. A Likert scale assessed reviewer confidence for each interpretation, and the primary reason guiding assessment of generated text was collected. AI output detector (0%‐100%) and plagiarism (0%‐100%) scores were evaluated using GPTZero. Results Reviewers correctly identified 62% of AI‐generated abstracts and misclassified 38% of original abstracts as being AI generated. GPTZero reported a significantly higher probability of AI output among generated abstracts (median, 56%; interquartile range [IQR], 51%‐77%) compared with original abstracts (median, 10%; IQR, 4%‐37%; P < .01). Generated abstracts scored significantly lower on the plagiarism detector (median, 7%; IQR, 5%‐14%) relative to original abstracts (median, 82%; IQR, 72%‐92%; P < .01). Correct identification of AI‐generated abstracts was predominately attributed to the presence of unrealistic data/values. The primary reason for misidentifying original abstracts as AI was attributed to writing style. Conclusions Experienced reviewers faced difficulties in distinguishing between human and AI‐generated research content within shoulder and elbow surgery. The presence of unrealistic data facilitated correct identification of AI abstracts, whereas misidentification of original abstracts was often ascribed to writing style. Clinical Relevance With rapidly increasing AI advancements, it is paramount that ethical standards of scientific reporting are upheld. It is therefore helpful to understand the ability of reviewers to identify AI‐generated content.
Characterization of the alcohol biomarker phosphatidylethanol in donor whole blood and apheresis red blood cells: Implications for transfusion recipients
Kinard, Theresa N. , Alegria, Kathy N., Langman, Loralie J., Jannetto, Paul J. , Snozek, Christine L.H. , Sharma, Pragya, Sharma, Pragya

Transfusion | July 9, 2024 | Volume: 64 | Issue: 9 | Pages: 1617-1622

10.1111/trf.17942 | PMID 38979963 Get It

AbstractIntroductionPhosphatidylethanol (PEth) is a long‐term marker of alcohol consumption used frequently in clinical scenarios such as liver transplant evaluation. Recent cases have demonstrated that packed red blood cell (pRBC) transfusion creates the potential for artificial elevation or decrease of observed PEth concentrations in recipients. Very little is known about the prevalence or stability of PEth in pRBCs.MethodsApheresis and whole‐blood (WB) donations were tested for PEth using liquid chromatography – tandem mass spectrometry with limit of quantitation 10 ng/mL. Units were stored under routine blood bank conditions to evaluate the stability of PEth and the impact of irradiation.ResultsOver 40% of apheresis and WB donors had PEth ≥10 ng/mL (maximum observed 587 ng/mL). As WB units were processed into component pRBCs, PEth concentrations increased and were higher than donor WB levels (EDTA sample) prior to collection (maximum observed 711 ng/mL). Storage for up to 5 weeks post donation resulted in mean 17.3% decrease in PEth‐positive units; in contrast to a prior report, we observed no PEth formation in units with negative (<10 ng/mL) baseline concentrations. Irradiation of pRBCs did not substantially affect PEth concentrations in either PEth‐positive or PEth‐negative units.DiscussionPEth concentrations in healthy blood donors may potentially confound alcohol use or abstinence assessment in pRBC recipients. Transfusion medicine services and clinical practices such as transplantation and behavioral medicine should recognize this phenomenon and collaborate on testing protocols to appropriately interpret PEth in pRBC recipients.
181 The work of shared decision-making: a systematic review
Huijgens, Fiorella, Torres, Ricardo Loor, Gravholt, Derek L. , Ayala, Ivan N, Kunneman, Marleen , Montori, Víctor M. , Huijgens, Fiorella L. , Pieterse, Arwen H. , Prokop, Larry J. , Gionfriddo, Michael R. , Suárez, Nataly R. Espinoza , Ayala, Ivan N. , Ridgeway, Jennifer L.

ISDM Conference – AMH Randomised Trial Abstract | July 9, 2024 | Volume: No volume available | Issue: No issue available | Pages: A83.2-A83

10.1136/bmjebm-2024-sdc.180 Get It

139 Pharmacists’ involvement in shared decision making: a scoping review
Langlois, Léa , Carnovale, Valérie, Stefan, Théo, Blouin, Patrick, Baron, Marie , Demers, Marie France, Kaufmann, Aline, Boily-Carette, Laury, Lavoie, Jean-Philippe C, Rivard, Louis S, Svyntozelska, Olha , Turmel, Audrey, Voyer, Laurie, Demers, Juliette , Jin, Jenny , Erwin, Patricia J., Prokop, Larry, Dugas, Michèle , Gionfriddo, Michael , Lavoie, Jean-Philippe C. , LeBlanc, Annie

ISDM Conference – AMH Randomised Trial Abstract | July 9, 2024 | Volume: No volume available | Issue: No issue available | Pages: A63.1-A63

10.1136/bmjebm-2024-sdc.138 Get It

Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans
Rajack, Fareed , Esnakula, Ashwini , Naab, Tammey , Kanaan, Yasmine , Ricks‐Santi, Luisel , Oladeru, Oluwadamilola, Rajack, Fareed , Esnakula, Ashwini , Ricks-Santi, Luisel , Oladeru, Oluwadamilola T.

Biomedicines | July 9, 2024 | Volume: 12 | Issue: 7 | Pages: 1522

10.3390/biomedicines12071522 | PMID 39062096 Get It

Quadruple-negative breast cancer (QNBC) is a triple-negative breast cancer (TNBC) subtype that lacks expression of the androgen (AR) receptor. Few studies have focused on this highly aggressive breast cancer, portending worse survival rates. We aimed to determine the following: (1) QNBC’s molecular and clinical characteristics and compare them with other subtypes and (2) QNBC’s association with clinicopathological factors and prognostic markers. We performed immunohistochemical evaluations of ARs on tissue tumor microarrays from FFPE tumor blocks of invasive ductal breast carcinomas in 202 African American women. Univariate analysis was performed using the chi-square test, with survival rates calculated using Kaplan–Meier curves. Overall, 75.8% of TNBCs were AR-negative. Compared to the luminal subtypes, TNBC and QNBC tumors were likely to be a higher grade (p < 0.001); HER2+/AR- and QNBCs were also larger than the other subtypes (p < 0.001). They also expressed increasing mean levels of proteins involved in invasion, such as CD44, fascin, and vimentin, as well as decreasing the expression of proteins involved in mammary differentiation, such as GATA3 and mammaglobin. We found no association between QNBC and stage, recurrence-free survival, or overall survival rates. The high prevalence of TNBC AR-negativity in these women could explain observed worse outcomes, supporting the existence of the unique QNBC subtype.